the selling price). After the disposal of all investments in NML, NML will cease to be a subsidiary of the Company. Nevertheless, it was uncertain if the Company and the Purchaser would be able to sign
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
(minute/s Postpaid Prepaid Blended VOU (GB/data s Postpaid Prepaid Blended Device Penetrat 4G‐handset Fixed Broadban FBB subscri FBB net add FBB ARPU ( 1H17 Snap For 1H17, AIS (excluding IC
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
Company hereby waives its rights to purchase 28,000,000 ordinary shares of Dhipaya Bodin or equivalent to 16.67% of the paid-up capital. All Dhipaya Bodin will seek the approval of the shareholders' meeting
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
continued to scale up several platforms to serve all customer segments. Our VDO, named AIS PLAY, received higher awareness, with current active subscribers growing to 4mn as we provided additional value for
in order to stabilize the financial system. Nevertheless, as the COVID-19 situation has shown no clear sign of improvement and may persist throughout the first half of this year or beyond, pending the
of 235k with increasing data volume of usage (VOU) to 7.5GB/data sub/month, up from 6.7GB in 2Q17. Prepaid segment saw a net loss of 523k due to prepaid-to-postpaid migration and least prepaid